JP2020511933A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511933A5
JP2020511933A5 JP2019527223A JP2019527223A JP2020511933A5 JP 2020511933 A5 JP2020511933 A5 JP 2020511933A5 JP 2019527223 A JP2019527223 A JP 2019527223A JP 2019527223 A JP2019527223 A JP 2019527223A JP 2020511933 A5 JP2020511933 A5 JP 2020511933A5
Authority
JP
Japan
Prior art keywords
biomarker
subject
sample
cell
results
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019527223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511933A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/063157 external-priority patent/WO2018098379A1/en
Publication of JP2020511933A publication Critical patent/JP2020511933A/ja
Publication of JP2020511933A5 publication Critical patent/JP2020511933A5/ja
Priority to JP2022116618A priority Critical patent/JP2022163076A/ja
Pending legal-status Critical Current

Links

JP2019527223A 2016-11-22 2017-11-22 癌検出のための方法 Pending JP2020511933A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022116618A JP2022163076A (ja) 2016-11-22 2022-07-21 癌検出のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662425549P 2016-11-22 2016-11-22
US62/425,549 2016-11-22
PCT/US2017/063157 WO2018098379A1 (en) 2016-11-22 2017-11-22 Methods for cancer detection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022116618A Division JP2022163076A (ja) 2016-11-22 2022-07-21 癌検出のための方法

Publications (2)

Publication Number Publication Date
JP2020511933A JP2020511933A (ja) 2020-04-23
JP2020511933A5 true JP2020511933A5 (enExample) 2021-01-14

Family

ID=62195635

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019527223A Pending JP2020511933A (ja) 2016-11-22 2017-11-22 癌検出のための方法
JP2022116618A Pending JP2022163076A (ja) 2016-11-22 2022-07-21 癌検出のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022116618A Pending JP2022163076A (ja) 2016-11-22 2022-07-21 癌検出のための方法

Country Status (8)

Country Link
US (1) US20200081008A1 (enExample)
EP (1) EP3544605A4 (enExample)
JP (2) JP2020511933A (enExample)
CN (1) CN110198711A (enExample)
CA (1) CA3044257A1 (enExample)
MA (1) MA46927A (enExample)
MX (1) MX2019006005A (enExample)
WO (1) WO2018098379A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3044257A1 (en) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Methods for cancer detection
CN108830045B (zh) * 2018-06-29 2021-04-20 深圳先进技术研究院 一种基于多组学的生物标记物系统筛选方法
KR102211972B1 (ko) * 2018-08-02 2021-02-04 엑소젠 피티이. 엘티디 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법
WO2020180896A1 (en) * 2019-03-03 2020-09-10 Purdue Research Foundation Systems and methods for identifying subtype, prognosis and monitoring of breast cancer
CN111679076A (zh) * 2020-06-15 2020-09-18 吉林医药学院 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒
US20210388451A1 (en) * 2020-06-16 2021-12-16 Grail, Inc. Methods for analysis of cell-free rna
CN111979321B (zh) * 2020-08-26 2022-07-12 郑州大学第一附属医院 用于胰腺癌检查的基因标记物
EP4208712A4 (en) * 2020-09-01 2024-12-11 Oncodea Corporation PREDICTIVE DIAGNOSTIC TEST FOR EARLY DETECTION AND MONITORING OF DISEASE
CN115927610B (zh) * 2022-07-19 2024-11-05 武汉艾米森生命科技有限公司 检测foxo6基因中目标区域的甲基化水平的试剂在制备膀胱癌诊断产品中的应用
WO2025005966A1 (en) * 2023-06-29 2025-01-02 Edge Animal Health, Inc. Urine pcr assay and use thereof to diagnose and stage feline chronic kidney disease

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US6358683B1 (en) * 1999-06-03 2002-03-19 The Regents Of The University Of California Blood-based assays for breast cancer
JP2008073304A (ja) * 2006-09-22 2008-04-03 Gifu Univ 超音波乳房診断システム
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
WO2011100472A1 (en) * 2010-02-10 2011-08-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
CA2803266A1 (en) * 2010-07-08 2012-01-12 Prime Genomics, Inc. System for the quantification of system-wide dynamics in complex networks
WO2012115885A1 (en) * 2011-02-22 2012-08-30 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers
KR101335034B1 (ko) * 2011-08-25 2013-12-02 주식회사 바이오인프라 유방암 진단을 위한 엑소좀 내의 ANT2 mRNA의 이용방법
AU2015210886A1 (en) * 2014-01-29 2016-09-01 Caris Mpi, Inc. Molecular profiling of immune modulators
WO2015187727A2 (en) * 2014-06-04 2015-12-10 Atossa Genetics Inc. Molecular mammography
WO2016004387A1 (en) * 2014-07-02 2016-01-07 H. Lee Moffitt Cancer Center And Research Institute, Inc. Gene expression signature for cancer prognosis
CA3044257A1 (en) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Methods for cancer detection

Similar Documents

Publication Publication Date Title
JP2020511933A5 (enExample)
Pandey et al. Correlation of altered expression of a long non-coding RNA, NEAT1, in peripheral blood mononuclear cells with dengue disease progression
JP2018518169A (ja) 非アルコール性脂肪肝疾患バイオマーカー
JP2022517456A (ja) 臓器健康および疾患をモニタリングするための方法およびシステム
US10907210B2 (en) Different levels in blood cell samples of EMT-markers for the diagnosis of cancer, in particular of colorectal (CRC) and pancreatic (PC) cancer
CN110205378B (zh) 一组脊柱结核血浆miRNA联合诊断标记物及其应用
CN106148524A (zh) 研究人体无精症和严重少精症快速检测的方法及应用其方法的试剂盒
CN119307611B (zh) 血液细胞外囊泡miRNA组合及其在肺癌早期诊断中的应用
CN111676291B (zh) 一种用于肺癌患病风险评估的miRNA标志物
TWI571514B (zh) 評估罹患大腸直腸癌風險的方法
CN105154533B (zh) 诊断早期肝癌的miRNA组合及其试剂盒
CN119491050B (zh) 血液小型胞外囊泡microRNA组合在肺癌诊断与鉴别诊断中的应用
CN108977533A (zh) 一种用于预测慢性乙肝炎症损伤的miRNA组合物
CN119736384A (zh) 血浆小型胞外囊泡miRNA标志物在制备肺癌免疫联合化疗疗效预测产品中的应用
EP3298165A1 (en) Method and kit for the diagnosis of colorectal cancer
CN115786505A (zh) 肺腺癌预后标志物的应用
CN106939354A (zh) miRNA‑4530作为肺癌诊断标志物的应用
CN120719025B (zh) mRNAs标志物在肺印戒细胞癌早期诊断中的应用及试剂盒
CN119307612B (zh) 血液胞外囊泡miRNA组合作为生物标志物在早期肺癌诊断中应用
CN120719024B (zh) 用于肺印戒细胞癌早期诊断的mRNAs标记物及试剂盒
CN106434907A (zh) miR‑495在作为检测强直性脊柱炎的标志物方面的应用
CN120574951A (zh) 用于肺癌免疫联合化疗疗效监测或预后的血浆胞外囊泡miRNA生物标志物及其应用
CN120442789A (zh) 血浆胞外囊泡miRNA标志物在制备肺癌免疫联合化疗疗效预测产品中的应用
WO2025074114A1 (en) Methods for diagnosing, treating and staging lung cancer
CN103865928B (zh) 可检测感染弓形虫的标识性mmu-miR-511-5p